Skip to main content

Table 1 Patient characteristics

From: Endothelium-derived microparticles from chronically thromboembolic pulmonary hypertensive patients facilitate endothelial angiogenesis

  Healthy CTEPH PE
N = 4 N = 6 N = 6
Males/females 2/2 2/4 2/4
Age, years 54 (42–60) 68 (52–81) 68 (45–91)
mPAP, mmHg - 42 (30–57) -
Warfarin/anticoagulants - 6 6
Ca channel blockers - 1 1
statins - 2 2
paracetamol/aspirin - 3 4
ET-1 antagonists - 5 -
Diuretics - 4 1
ACE inhibitors - 2 1
Angiotensin II antagonists - - 1
β-blockers - 1 4